MSI PIs Receive Grant to Fight Inflammatory Disease
Two MSI PIs in the Department of Pediatrics, Associate Professors Branden Moriarity and Beau Webber, have been awarded a $11.6 million grant that funds research into new treatments for chronic inflammatory diseases. The project, which is a joint effort with other universities and biotech companies, aims to develop an implantable device that houses bioengineered cells that could produce anti-inflammatory therapeutics to fight chronic diseases such as Crohn’s disease and ulcerative colitis. Professors Moriarity and Webber are leading the cell engineering team. A story about this project appears on the Medical School’s website: U of M Medical School researchers secure $11.6M for inflammatory disease research.
Professor Moriarity uses MSI for research into the genetics of pediatric cancer. Professor Webber uses MSI in research aimed at developing novel treatments for genetic diseases and cancer.
